128 related articles for article (PubMed ID: 2450423)
1. Epitope mosaic on the surface proteins of orthopoxviruses.
Ichihashi Y; Oie M
Virology; 1988 Mar; 163(1):133-44. PubMed ID: 2450423
[TBL] [Abstract][Full Text] [Related]
2. Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections.
Zhao R; Wu L; Sun J; Liu D; Han P; Gao Y; Zhang Y; Xu Y; Qu X; Wang H; Chai Y; Chen Z; Gao GF; Wang Q
Nat Commun; 2024 May; 15(1):4660. PubMed ID: 38821921
[TBL] [Abstract][Full Text] [Related]
3. Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses - Target Selection and Optimized Screening.
Stern D; Pauly D; Zydek M; Miller L; Piesker J; Laue M; Lisdat F; Dorner MB; Dorner BG; Nitsche A
PLoS One; 2016; 11(3):e0150110. PubMed ID: 26930499
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection.
Tamir H; Noy-Porat T; Melamed S; Cherry-Mimran L; Barlev-Gross M; Alcalay R; Yahalom-Ronen Y; Achdout H; Politi B; Erez N; Weiss S; Rosenfeld R; Epstein E; Mazor O; Makdasi E; Paran N; Israely T
Nat Commun; 2024 Apr; 15(1):3265. PubMed ID: 38627363
[TBL] [Abstract][Full Text] [Related]
5. Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus.
Rohaim MA; Naggar RFE; Atasoy MO; Munir M
Adv Exp Med Biol; 2024; 1451():111-124. PubMed ID: 38801574
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection.
Manenti A; Solfanelli N; Cantaloni P; Mazzini L; Leonardi M; Benincasa L; Piccini G; Marchi S; Boncioli M; Spertilli Raffaelli C; Tacconi D; Mattiuzzo G; Kistner O; Montomoli E; Trombetta CM
Front Public Health; 2023; 11():1195674. PubMed ID: 37415699
[TBL] [Abstract][Full Text] [Related]
7. Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.
Townsend MB; Keckler MS; Patel N; Davies DH; Felgner P; Damon IK; Karem KL
J Virol; 2013 Jan; 87(2):900-11. PubMed ID: 23135728
[TBL] [Abstract][Full Text] [Related]
8. Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice.
Tscharke DC; Woo WP; Sakala IG; Sidney J; Sette A; Moss DJ; Bennink JR; Karupiah G; Yewdell JW
J Virol; 2006 Jul; 80(13):6318-23. PubMed ID: 16775319
[TBL] [Abstract][Full Text] [Related]
9. In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses.
Moin AT; Rani NA; Patil RB; Robin TB; Ullah MA; Rahim Z; Rahman MF; Zubair T; Hossain M; Mollah AKMM; Absar N; Hossain M; Manchur MA; Islam NN
PLoS One; 2024; 19(5):e0300778. PubMed ID: 38758816
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies for differentiating infections of three serological-related tospoviruses prevalent in Southwestern China.
Chen YH; Dong J; Chien WC; Zheng K; Wu K; Yeh SD; Sun JH; Wang YC; Chen TC
Virol J; 2016 Apr; 13():72. PubMed ID: 27121504
[TBL] [Abstract][Full Text] [Related]
11. Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.
Siciliano NA; Hersperger AR; Lacuanan AM; Xu RH; Sidney J; Sette A; Sigal LJ; Eisenlohr LC
J Virol; 2014 Sep; 88(17):10078-91. PubMed ID: 24965457
[TBL] [Abstract][Full Text] [Related]
12. Age-related antibody response to Orthopoxviruses and implications for public health measures: Insights from a South Korean study.
Kim Y; Kim G; Min G; Woo Y; Peck KR; Hong JJ; Kim SB
J Infect Public Health; 2024 Jun; 17(6):956-960. PubMed ID: 38608456
[TBL] [Abstract][Full Text] [Related]
13. EPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome between Variola Virus and Related Pathogenic Orthopoxviruses.
Molero-Abraham M; Glutting JP; Flower DR; Lafuente EM; Reche PA
J Immunol Res; 2015; 2015():738020. PubMed ID: 26605344
[TBL] [Abstract][Full Text] [Related]
14. A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models.
Su C; Li S; Wen Y; Geng X; Yin Q; Wang Y; Xiong Y; Liu Z
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675767
[TBL] [Abstract][Full Text] [Related]
15. Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.
Parker S; Siddiqui AM; Painter G; Schriewer J; Buller RM
Viruses; 2010 Sep; 2(9):1918-1932. PubMed ID: 21994714
[TBL] [Abstract][Full Text] [Related]
16. Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus.
Rubins KH; Hensley LE; Relman DA; Brown PO
PLoS One; 2011 Jan; 6(1):e15615. PubMed ID: 21267444
[TBL] [Abstract][Full Text] [Related]
17. Shared immunogenic epitopes between host entry and exit proteins from monkeypox and Alaskapox viruses.
de Araújo LP; Silva EN; Corsetti PP; de Almeida LA
Lancet Microbe; 2024 Apr; ():. PubMed ID: 38653317
[No Abstract] [Full Text] [Related]
18. Monkeypox and the eye.
Sibeveih Z
Med Hypothesis Discov Innov Ophthalmol; 2023; 12(3):157-159. PubMed ID: 38476572
[No Abstract] [Full Text] [Related]
19. Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses?
Douglass N
Lancet Microbe; 2024 May; ():. PubMed ID: 38735304
[No Abstract] [Full Text] [Related]
20. Mpox: a review of laboratory detection techniques.
Zhou Y; Chen Z
Arch Virol; 2023 Aug; 168(8):221. PubMed ID: 37543543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
